AI assistant
BioCardia, Inc. — Director's Dealing 2019
Aug 23, 2019
35081_dirs_2019-08-23_db9b056a-0ee1-4732-8cb3-4eef3ce6bed6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2019-07-26
Reporting Person: MOYES JAY M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-26 | Common Stock | M | 3594 | — | Acquired | 3961 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-26 | Restricted Stock Units | $0 | M | 3594 | Disposed | Common Stock (3594) | Direct |
Footnotes
F1: Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018.
F2: The converted RSU corresponds to a 1:1 common stock issuance.
F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.